|
Kronschnabl P, Grünweller A,
Hartmann RK,Aigner A, Weirauch U
Inhibition of PIM2 in liver cancer decreases tumor cell proliferation
in vitro and in vivo primarily through the modulation of cell cycle
progression.
Int J Oncol 2020; 56 (2): 448-459
Kunz M, Brandl M, Bhattacharya A,
Nobereit-Siegel L, Ewe A, Weirauch U,, Hering D,
Reinert A, Kalwa H, Guzman J, Weigelt K, Wach S, Taubert S, Aigner
A
Nanoparticle-complexed antimiRs forinhibiting tumor growth and
metastasis in prostate carcinoma and melanoma
J Nanobiotechnology 2020; 18 (1) : 173
Noske S,
Karimov M, Aigner A, Ewe A
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine
(PEI)strongly improves efficacy ofsiRNA-mediated gene knockdown
Nanomaterials (Basel) 2020; 10(9): 1809
Panchal O, Wichmann G, GrenmanR, Eckhardt L,
Kunz-Schughart LA, Franke H, Dietz A,Aigner A
SATB1 as oncogenic driver and potential therapeutic target in head
& neck squamous cell carcinoma (HNSCC).
Sci Rep 2020; 10 (1): 8615
Sideorenco V, Krahnen L, Schulz M, Remy J,
Kögel D, Temme A, Krügel U, Franke H,Aigner A
Glioblastoma Tissue Slice TAndem-Cultures for Quantitative Evaluation
of Inhibitory Effects on Invasion and Growth
Cancers (Basel) 2020; 12 (9): 2707
Teichert J, Rowe JB,
Ersche KD,Skandali N, Sacher J,
Aigner A, Regenthal R
Determination of atomoxetine or escitalopram in human plasma by HPLC:
Applications in neuroscience research studies
Int J Clin Pharmacol Ther 2020; 58 (8): 426-438
Zhupanyn P, Ewe A, Büch T,Malek
A, Rademacher P, Müller C, Reinert A, Jaimes Y,
Aigner
A
Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes
for enhanced siRNA delivery in vitro and in vivo.
J ControlRelease 2020; 319: 63-76
Böckelmann L, Starzonek C, Niehoff
AC, Karst U, Thomale J, Schlüter H, Bokemeyer CAigner
A,
Schumacher U
Detection of doxorubicin, cisplatin and therapeutic antibodies in
formalin-fixed parrafin-embedded human cancer cells.
Histochem Cell Biol 2020; 155 (5): 367-377
Friedrich M, Wiedemann K, Reiche K, Puppel
SH, Pfeifer G, Zipfel I, Binder S, Köhl U, Müller GA,
Engeland K, Aigner A,
Füssel S, Fröhner M, Peitzsch C, Dubrovska A, Rade M,
Christ S, Schreiber S, Hackermüller J, Lehmann J, Toma MI,
Muders MH, Sommer U, Baretton GB, Wirth M, Horn F
The role of IncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential
Therapeutic Targets in Prostate Cancer.
Cancers (Basel) 2020; 30: 1122
Molloy EN, Mueller K, Beinhölzl N,
Blöchl M, Piecha FA, Pampel A, Steele CJ, Scharrer U, Zheleva
G Regenthal R, Sehm B, Nikulin VV, Möller
HE, Villringer A, Sacher J
Modulation of premotor cortex response to sequence motor
learning during escitalopram intake.
J Cereb Blood Flow Metab 2020; Nov 4: 271678-20965161
Schellenberg LM, Bonicelli J, Hochheim I, Regenthal
R, Abraham G
Presence and function of beta-adrenergic receptors in primeary equine
bronchial epithelia cells
Pulm Pharmacol Ther 2020; 61: 101897
Wenzel T,Büch T,Urban
N, Weirauch U,Schierle K,Aigner A,Schaefer
M, Kalwa H
Restoration of MARCKS enhances chemosensitivity in cancer.
J Cancer Res Clin Oncol 2020; 146 (4): 843-858
Wenzel T,Büch T,Urban
N, Weirauch U,Schierle K, Aigner A,Schaefer
M, Kalwa H
Correction to: Restoration of MARCKS enhances chemosensitivity in cancer
J Cancer Res Clin Oncol 2020; 146(4): 859
Wernly B, Paar V,Aigner A,Pilz
PM, Podesser BK, Förster M, Jung C, Hofbauer JP, Tockner B,
Wimmer M, Kraus T, Motloch LJ, Hackl M, HoppeUC, Kiss A, Lichtenauer M
Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of
Myocardial Infarction.
Cells 2020; 9(2): 295
|